CKD 843
Alternative Names: CKD-843; CKD-843 A; CKD-843 BLatest Information Update: 28 May 2024
At a glance
- Originator Chong Kun Dang
- Class Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Alopecia
Most Recent Events
- 28 May 2024 No recent reports of development identified for phase-I development in Alopecia(In volunteers) in South Korea (PO)
- 17 Oct 2023 Chong Kun Dang Pharmaceutical Completes a phase I trial in Alopecia (In volunteers) in South Korea (IV) (Injection) (NCT05587699)
- 15 Nov 2022 Phase-I clinical trials in Alopecia (In volunteers) in South Korea (IV) (NCT05587699)